ACLARION INC (ACON:NASDAQ)
$2.34 0.03 (1.2987%)
Analysed ACLARION INC (ACON:NASDAQ) News Sources
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
01-06-2026
yahoo.com
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
03-06-2026
yahoo.com
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
08-06-2026
yahoo.com
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal
08-06-2026
yahoo.com
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
09-06-2026
yahoo.com
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
06-08-2026
yahoo.com
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
12-08-2026
yahoo.com
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
20-08-2026
yahoo.com
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
29-09-2026
yahoo.com
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
08-10-2026
yahoo.com
What is the current price of ACLARION INC (ACON:NASDAQ)?
The current price of ACLARION INC (ACON:NASDAQ) is $2.34.
ACLARION INC (ACON:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACLARION INC (ACON:NASDAQ) since the previous trading day is $0.03.
ACLARION INC (ACON:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACLARION INC (ACON:NASDAQ) since the previous trading day is 1.2987%.
What is the most recent average sentiment score for ACLARION INC (ACON:NASDAQ)?
The most recent average sentiment score for ACLARION INC (ACON:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for ACLARION INC (ACON:NASDAQ)?
The most recent sentiment for ACLARION INC (ACON:NASDAQ) is .
SEC-8K** Filing Available For ACLARION INC (ACON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.